The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes
Authors:
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 174 (1) , 141-149
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseAtherosclerosis, 2003
- Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemiaAmerican Heart Journal, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes MellitusAnnals of Internal Medicine, 2001
- Action of Atorvastatin in Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Apolipoprotein B-100 Conformation and Particle Surface Charge in Human LDL Subspecies: Implication for LDL Receptor InteractionBiochemistry, 1998
- Lipoprotein Heterogeneity and Apolipoprotein B MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 1997
- Low-density lipoprotein subclass patterns and risk of myocardial infarctionJAMA, 1988
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979